Clinical Operations and Strategy

The Clinical Operations and Strategy team at Rexahn Pharmaceuticals is responsible for designing and overseeing clinical trials aimed at evaluating the efficacy and safety of novel treatments for cancer and central nervous system disorders. They develop clinical development plans, ensure regulatory compliance, and collaborate with scientific experts to advance the company’s drug candidates through the clinical pipeline, while strategically aligning clinical activities with broader organizational goals.